What are Antibiotic and antifungal combination drugs?

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Antibiotic and antifungal combination drugs are pharmacologic agents that share a common mechanism (typically targeting Bacterial cell wall synthesis and fungal cell membrane function). 0 are currently marketed, with 3 more in clinical development.

Antibiotic and antifungal combination

0 marketed 2 in Phase 3 1 in Phase 2

This page covers all Antibiotic and antifungal combination drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Bacterial cell wall synthesis and fungal cell membrane function.

Targets

Bacterial cell wall synthesis and fungal cell membrane function

Phase 3 pipeline (2)

clindamycin phosphate/butoconazole nitrate · Lumara Health, Inc. · Fungal infections, Bacterial infections
Clindamycin phosphate/butoconazole nitrate is an antibiotic and antifungal combination that works by inhibiting bacterial cell wall synthesis and disrupting fungal cell membranes.
POLYGYNAX® · Laboratoire Innotech International · Infectious Disease / Gynecology
POLYGYNAX is a vaginal capsule containing a combination of antibiotics and antifungal agents that eliminates pathogenic bacteria and fungi in the vaginal tract.

Phase 2 pipeline (1)

Antibiotic and antifungal drugs · Gruppo Italiano Malattie EMatologiche dell'Adulto · Infectious Diseases
Antibiotic and antifungal drugs work by inhibiting bacterial cell wall synthesis and interfering with fungal cell membrane function.

Patent intelligence

antibiotic and antifungal patent landscape — aggregated cliff calendar, attackable patents, originator estates